SG Americas Securities
CKPT

SG Americas Securities’s Checkpoint Therapeutics CKPT Stock Holding History

SG Americas Securities’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,231
Closed -$44K – 2805
2020
Q2 		$44K Buy
2,231
+1,019
+84% +$18.6K ﹤0.01% 3550
2020
Q1 		$18K Buy
+1,212
New +$21.5K ﹤0.01% 3310

Other funds holding CKPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

SG Americas Securities's CKPT Position: Q3 2020 in Review

SG Americas Securities sold out of Checkpoint Therapeutics (CKPT) in Q3 2020, closing a stake of 2,231 shares — an estimated $44K sold.

SG Americas Securities first reported a position in CKPT in Q1 2020 and held it in 2 quarters. The position peaked at $44K in Q2 2020. 53 funds tracked by Wall St. Rank hold CKPT as of Q3 2020.

  • SG Americas Securities reported no remaining Checkpoint Therapeutics position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 2,231 Checkpoint Therapeutics shares in Q3 2020, an estimated $44K.
  • SG Americas Securities first reported a position in Checkpoint Therapeutics in Q1 2020 and held it in 2 quarters.
  • SG Americas Securities's Checkpoint Therapeutics position peaked at $44K in Q2 2020.
  • 53 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.